Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial updating safety, tolerability and efficacy of eribulin mesylate in adult females with locally advanced or metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

Sponsor: Eisai Inc. | Conditions: Breast Neoplasms | Phase 4 | Status: COMPLETED